A carregar...
Small Molecule Inhibitors in Acute Myeloid Leukemia: From the Bench to the Clinic
Many patients with acute myeloid leukemia (AML) will eventually develop refractory or relapsed disease. In the absence of standard therapy for this population, there is currently an urgent unmet need for novel therapeutic agents. Targeted therapy with small molecule inhibitors (SMIs) represents a ne...
Na minha lista:
| Publicado no: | Expert Rev Hematol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4283573/ https://ncbi.nlm.nih.gov/pubmed/25025370 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/17474086.2014.932687 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|